Pharma-grade menthol API licensing

L-menthol supply in 2026 is dominated by conventional routes under active capacity expansion — BASF's triple-digit-million-euro world-scale menthol/linalool plant at Ludwigshafen (Apr 2026) and Symrise's 50-year synthetic-menthol franchise in the EU, alongside NMPA-licensed API extraction (Huangshan Tianmu Mint Pharmaceutical, license renewed to 2030) and food-grade dispersion formulation (Jiangsu Caiwei, 0.001-0.5% precision dosing) in China — while dedicated fermentation-route biosynthesis remains at the academic/patent stage with no company-specific commercial originator confirmed.